Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15101725rdf:typepubmed:Citationlld:pubmed
pubmed-article:15101725lifeskim:mentionsumls-concept:C0026764lld:lifeskim
pubmed-article:15101725lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:15101725lifeskim:mentionsumls-concept:C0206431lld:lifeskim
pubmed-article:15101725lifeskim:mentionsumls-concept:C0005516lld:lifeskim
pubmed-article:15101725lifeskim:mentionsumls-concept:C0332152lld:lifeskim
pubmed-article:15101725lifeskim:mentionsumls-concept:C0439661lld:lifeskim
pubmed-article:15101725lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:15101725pubmed:issue2lld:pubmed
pubmed-article:15101725pubmed:dateCreated2004-4-22lld:pubmed
pubmed-article:15101725pubmed:abstractTextMurine T cells do not endogenously upregulate CD80 expression but rather acquire CD80 from antigen presenting cells (APC) during CD28 ligation. Murine CD80+ memory T cells undergo apoptosis in the presence of high levels of antigen while naive CD80+ T cells are capable of acting as APC and T cell:T cell ligation induces anergy and unresponsiveness to antigen rechallenge. Reversing T cell unresponsiveness may be a key factor in the development of immunotherapy strategies for patients with myeloma. We have determined that B7+ T cells (CD80+ or CD86+) are common in patients with myeloma (n = 45), can be either CD4 or CD8, tend to be associated with stable disease and are polyclonal memory T cells (CD45RO). CD80 mRNA expression was present in CD80+ monocytes but not in CD3+ cells with a similar level of CD80 antigen expression. CD80 and CD86 antigen expression was upregulated on B cells but not T cells during incubation with trimeric human CD40 ligand (huCD40LT) + IL-2. Although there was a gradual loss of expression during in vitro culture, CD80+ T cells could be purified for further study. We conclude that B7 expression is common on T cells of patients with myeloma but that this is acquired rather than endogenously produced. B7+ CD45RO+ T cells constitute a population of memory T cells chronically exposed to antigen and warrant further study.lld:pubmed
pubmed-article:15101725pubmed:languageenglld:pubmed
pubmed-article:15101725pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15101725pubmed:citationSubsetIMlld:pubmed
pubmed-article:15101725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15101725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15101725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15101725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15101725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15101725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15101725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15101725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15101725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15101725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15101725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15101725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15101725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15101725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15101725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15101725pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15101725pubmed:statusMEDLINElld:pubmed
pubmed-article:15101725pubmed:monthFeblld:pubmed
pubmed-article:15101725pubmed:issn1042-8194lld:pubmed
pubmed-article:15101725pubmed:authorpubmed-author:GibsonJohnJlld:pubmed
pubmed-article:15101725pubmed:authorpubmed-author:PopeBelindaBlld:pubmed
pubmed-article:15101725pubmed:authorpubmed-author:BrownRossRlld:pubmed
pubmed-article:15101725pubmed:authorpubmed-author:HoP JoyPJlld:pubmed
pubmed-article:15101725pubmed:authorpubmed-author:SzeDanielDlld:pubmed
pubmed-article:15101725pubmed:authorpubmed-author:MurrayAllanAlld:pubmed
pubmed-article:15101725pubmed:authorpubmed-author:JoshuaDougDlld:pubmed
pubmed-article:15101725pubmed:issnTypePrintlld:pubmed
pubmed-article:15101725pubmed:volume45lld:pubmed
pubmed-article:15101725pubmed:ownerNLMlld:pubmed
pubmed-article:15101725pubmed:authorsCompleteYlld:pubmed
pubmed-article:15101725pubmed:pagination363-71lld:pubmed
pubmed-article:15101725pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:meshHeadingpubmed-meshheading:15101725...lld:pubmed
pubmed-article:15101725pubmed:year2004lld:pubmed
pubmed-article:15101725pubmed:articleTitleB7+ T cells in myeloma: an acquired marker of prior chronic antigen presentation.lld:pubmed
pubmed-article:15101725pubmed:affiliationInstitute of Haematology, Royal Prince Alfred Hospital, Sydney, NSW Australia. rbrown@haem.rpa.cs.nsw.gov.aulld:pubmed
pubmed-article:15101725pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15101725pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15101725lld:pubmed